Current Gene Therapy ISSN (Print): 1566-5232 ISSN (Online): 1875-5631
journal

Impact Factor

 4.1

CiteScore

 6.7

Avg. time to 1st decision

 8 days

Publishing options for this journal

Article Processing Charges

$890

Article Processing Charges (APC), excluding taxes

Subject area
Genetics & Genomics, Genetics & Heredity, Life Sciences, Molecular Medicine
Journal scope

Current Gene Therapy is a bi-monthly peer-reviewed journal aimed at academic and industrial scientists with an interest in major topics concerning basic research and clinical applications of gene and cell therapy of diseases. Cell therapy manuscripts can also include application in diseases when cells have been genetically modified. Current Gene Therapy publishes full-length/mini reviews and original research on the latest developments in gene transfer and gene expression analysis, vector development, cellular genetic engineering, animal models and human clinical applications of gene and cell therapy for the treatment of diseases.

Current Gene Therapy publishes reviews and original research containing experimental data on gene and cell therapy. The journal also includes manuscripts on technological advances, ethical and regulatory considerations of gene and cell therapy. Reviews should provide the reader with a comprehensive assessment of any area of experimental biology applied to molecular medicine that is not only of significance within a particular field of gene therapy and cell therapy but also of interest to investigators in other fields. Authors are encouraged to provide their own assessment and vision for future advances. Reviews are also welcome on late breaking discoveries on which substantial literature has not yet been amassed. Such reviews provide a forum for sharply focused topics of recent experimental investigations in gene therapy primarily to make these results accessible to both clinical and basic researchers. Manuscripts containing experimental data should be original data, not previously published.

Current Gene Therapy is an international, peer-reviewed journal on all aspects of gene and cell therapy, published bi-monthly (print & online) by Bentham Science Publishers.

Mini-Reviews in Medicinal Chemistry ISSN (Print): 1389-5575 ISSN (Online): 1875-5607
journal

Impact Factor

 4

CiteScore

 7.5

Avg. time to 1st decision

 7 days

Publishing options for this journal

Article Processing Charges

$3450

Article Processing Charges (APC), excluding taxes

Subject area
Biochemistry and Molecular Biology, Pharmaceutical and Medicinal Chemistry, Pharmacology
Journal scope

The aim of Mini-Reviews in Medicinal Chemistry is to publish short reviews on the important recent developments in medicinal chemistry and allied disciplines.

Mini-Reviews in Medicinal Chemistry covers all areas of medicinal chemistry, including quantitative structure-function relationships, synthetic chemistry, bioorganic chemistry, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug safety profile and drug-induced liver injury (DILI), drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization and organic syntheses of naturally occurring compounds, "nanosystem and nanocarriers", as well as chemical and analytical techniques used in rational drug design.

Mini-Reviews in Medicinal Chemistry is an essential journal for every medicinal and pharmaceutical chemist who wishes to remain  informed and up-to-date with the latest and most important developments.

Mini-Reviews in Medicinal Chemistry is an international, peer-reviewed journal on all aspects of medicinal chemistry, published bi-weekly (print & online) by Bentham Science Publishers.

Current Genomics ISSN (Print): 1389-2029 ISSN (Online): 1875-5488
journal

Impact Factor

 4

CiteScore

 3.7

Avg. time to 1st decision

 7 days

Publishing options for this journal

Article Processing Charges

$3450

Article Processing Charges (APC), excluding taxes

Subject area
Genetics & Genomics, Genetics & Heredity, Life Sciences
Journal scope

Current Genomics is a peer-reviewed journal that provides essential reading about the latest and most important developments in genome science and related fields of research. Systems biology, systems modeling, machine learning, network inference, bioinformatics, computational biology, epigenetics, single-cell genomics, extracellular vesicles, quantitative biology, and synthetic biology for the study of evolution, development, maintenance, aging, and that of human health, human diseases, clinical genomics, and precision medicine are topics of particular interest. The journal also covers plant genomics. The journal does not consider articles dealing with breeding and livestock.

Current Genomics publishes three types of articles including:

i) Research papers from internationally recognized experts reporting on new and original data generated at the genome-scale level. Position papers dealing with new or challenging methodological approaches, whether experimental or mathematical, are greatly welcome in this section.

ii) Authoritative and comprehensive full-length or mini-reviews from widely recognized experts, covering the latest developments in genome science and related fields of research, such as systems biology, statistics and machine learning, quantitative biology, and precision medicine. Proposals for mini-hot topics (2-3 review papers) and full hot topics (6-8 review papers) guest-edited by internationally recognized experts are welcome in this section. Hot topic proposals should not contain original data, and they should contain articles originating from at least 2 different countries.

iii) Opinion papers from internationally recognized experts addressing contemporary questions and issues in the field of genome science and systems biology and basic and clinical research practices.

Current Genomics is an international, peer-reviewed journal on all aspects of Genomics, published bi-monthly (print & online) by Bentham Science Publishers.

Current Topics in Medicinal Chemistry ISSN (Print): 1568-0266 ISSN (Online): 1873-4294
journal

Impact Factor

 3.6

CiteScore

 6.6

Avg. time to 1st decision

 7 days

Publishing options for this journal

Article Processing Charges

$2950

Article Processing Charges (APC), excluding taxes

Subject area
Biochemistry and Molecular Biology, Immunology, Inflammation & Allergy, Pharmaceutical and Medicinal Chemistry, Pharmacology
Journal scope

Current Topics in Medicinal Chemistry is a forum for the review of areas of keen and topical interest to medicinal chemists and others in the allied disciplines. Each issue is solely devoted to in-depth mini-reviews/ research and guest-edited reviews/ research which provide the reader with a comprehensive survey of that respective area. A Guest Editor who is an expert in the topic under review will assemble each issue. The scope of Current Topics in Medicinal Chemistry will cover all areas of medicinal chemistry, including current developments in rational drug design, synthetic chemistry, bioorganic chemistry, high-throughput screening, combinatorial chemistry, compound diversity measurements, drug absorption, drug distribution, metabolism, new and emerging drug targets, natural products, pharmacogenomics, and structure-activity relationships. Medicinal chemistry is a rapidly maturing discipline. Understanding the relationship between structure and function is crucial to understand the molecular basis of life. Current Topics in Medicinal Chemistry aims to contribute to the growth of scientific knowledge and insight and facilitate the discovery and development of new therapeutic agents to treat debilitating human disorders. The journal is essential for every medicinal chemist who wishes to be informed and up-to-date with the latest and most important advances.

Current Topics in Medicinal Chemistry is an international, peer-reviewed journal on all aspects of medicinal chemistry, published weekly (print & online) by Bentham Science Publishers.

Current Drug Targets ISSN (Print): 1389-4501 ISSN (Online): 1873-5592
journal

Impact Factor

 3.5

CiteScore

 6.0

Avg. time to 1st decision

 8 days

Publishing options for this journal

Article Processing Charges

$2950

Article Processing Charges (APC), excluding taxes

Subject area
Drug Design & Discovery, Pharmacology
Journal scope

Current Drug Targets aims to cover the latest and most outstanding developments in medicinal chemistry and pharmacology of molecular drug targets, e.g., disease-specific proteins, receptors, enzymes, and genes.

Current Drug Targets publishes guest-edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts full-length/mini-review articles and drug clinical trial studies for publication.

As the discovery, identification, characterization, and validation of novel human drug targets for drug discovery continue to grow, this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Current Drug Targets is an international, peer-reviewed journal on all aspects of drug targets, published monthly (print & online) by Bentham Science Publishers.

CNS & Neurological Disorders - Drug Targets ISSN (Print): 1871-5273 ISSN (Online): 1996-3181
journal

Impact Factor

 3.3

CiteScore

 7.3

Avg. time to 1st decision

 8 days

Publishing options for this journal

Article Processing Charges

$3645

Article Processing Charges (APC), excluding taxes

Subject area
Neurology, Neurology, Pharmacology
Journal scope

CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding developments in medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry of contemporary molecular targets involved in neurological and central nervous system (CNS) disorders, e.g., disease-specific proteins, receptors, enzymes, and genes.

CNS & Neurological Disorders - Drug Targets publishes guest-edited thematic issues written by leaders in the field covering a range of current topics of CNS & neurological drug targets. The journal also accepts original research articles, letters, reviews, and drug clinical trial studies for publication.

As the discovery, identification, characterization, and validation of novel human drug targets for neurological and CNS drug discovery continue to grow, this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

CNS & Neurological Disorders - Drug Targets is an international, peer-reviewed journal on all aspects of neurological disorders, published monthly (print & online) by Bentham Science Publishers.

Current Medicinal Chemistry ISSN (Print): 0929-8673 ISSN (Online): 1875-533X
journal

Impact Factor

 3.2

CiteScore

 6.5

Avg. time to 1st decision

 8 days

Publishing options for this journal

Article Processing Charges

$3940

Article Processing Charges (APC), excluding taxes

Subject area
Anti-Infectives and Infectious Diseases, Biochemistry and Molecular Biology, Chemistry, Drug Design & Discovery, Immunology, Inflammation & Allergy, Medicinal Chemistry, Pharmacology
Journal scope

Current Medicinal Chemistry covers all the latest and outstanding developments in the field of medicinal chemistry. It also includes topics related to quantitative structure-function relationships, drug absorption, drug distribution, drug metabolism, new and emerging drug targets, pharmacogenomics, drug discovery toxicology, high-throughput screening, combinatorial chemistry, structural characterization, and organic syntheses of naturally occurring compounds, as well as chemical and analytical techniques used in rational drug design. Each issue incorporates a series of timely, in-depth/mini-reviews and guest-edited thematic issues written by leaders in the field, covering a range of  current topics in medicinal chemistry. The journal also publishes reviews on recent patents.

Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be informed and remain up-to-date with the latest and most important developments relevant to their field.

Current Medicinal Chemistry is an international, peer-reviewed journal on all aspects of medicinal chemistry, published weekly (print & online) by Bentham Science Publishers.

Current Pharmaceutical Design ISSN (Print): 1381-6128 ISSN (Online): 1873-4286
journal

Impact Factor

 3.2

CiteScore

 5.8

Avg. time to 1st decision

 7 days

Publishing options for this journal

Article Processing Charges

$3425

Article Processing Charges (APC), excluding taxes

Subject area
Immunology, Inflammation & Allergy, Pharmacology
Journal scope

Current Pharmaceutical Design publishes timely in-depth reviews/mini reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field.

Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.

Current Pharmaceutical Design is an international, peer-reviewed journal on all aspects of pharmaceutical design, published weekly (print & online) by Bentham Science Publishers

Current Drug Delivery ISSN (Print): 1567-2018 ISSN (Online): 1875-5704
journal

Impact Factor

 3.1

CiteScore

 6.9

Avg. time to 1st decision

 8 days

Publishing options for this journal

Article Processing Charges

$990

Article Processing Charges (APC), excluding taxes

Subject area
Drug Delivery, Drug Delivery, Drug Design, Discovery and Therapy, Pharmacology
Journal scope

Current Drug Delivery aims to publish peer-reviewed articles, research articles, in-depth reviews/mini-reviews, and drug clinical trial studies in the rapidly developing field of drug delivery. Modern drug research aims to build the delivery properties of a drug at the design phase; however, in many cases, this idea cannot be met and the development of delivery systems becomes as important as the development of the drugs themselves.

The journal aims to cover the latest outstanding developments in drug and vaccine delivery employing physical, physico-chemical, and chemical methods. The drugs include a wide range of bioactive compounds, from simple pharmaceuticals to peptides, proteins, nucleotides, nucleosides, and sugars. The journal will also report progress in the fields of transport routes and mechanisms, including efflux proteins and multi-drug resistance.

The journal is essential for all pharmaceutical scientists involved in drug design, development, and delivery.

Current Drug Delivery is an international, peer-reviewed journal on all aspects of drug delivery, published monthly (print & online) by Bentham Science Publishers.

Current Pharmaceutical Biotechnology ISSN (Print): 1389-2010 ISSN (Online): 1873-4316
journal

Impact Factor

 2.9

CiteScore

 5.9

Avg. time to 1st decision

 7 days

Publishing options for this journal

Article Processing Charges

$3695

Article Processing Charges (APC), excluding taxes

Subject area
Applied Microbiology, Biotechnology, Drug Design & Discovery, Pharmacology
Journal scope

Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal includes timely in-depth/ mini-reviews, original research articles, and letters written by leaders in the field, covering a range of current topics in scientific areas of Pharmaceutical Biotechnology. Invited and unsolicited review articles are welcome. The journal encourages contributions describing research at the interface of drug discovery and pharmacological applications, involving in vitro investigations and pre-clinical or clinical studies. Scientific areas within the scope of the journal include pharmaceutical chemistry, biochemistry and genetics, molecular and cellular biology, and polymer and materials sciences, as they are related to pharmaceutical science and biotechnology. In addition, the journal also considers comprehensive studies and research advances pertaining to food chemistry with pharmaceutical implications. Areas of interest include:

●     DNA/protein engineering and processing
●     Synthetic biotechnology
●     Omics (genomics, proteomics, metabolomics, and systems biology)
●     Therapeutic biotechnology (gene therapy, peptide inhibitors, and enzymes)
●     Drug delivery and targeting
●     Nanobiotechnology
●     Molecular pharmaceutics and molecular pharmacology
●     Analytical biotechnology (biosensing, advanced technology for detection of bioanalytes)
●     Pharmacokinetics and pharmacodynamics
●     Applied Microbiology
●     Bioinformatics (computational biopharmaceutics and modeling)
●     Environmental biotechnology
●     Regenerative medicine (stem cells, tissue engineering, and biomaterials)
●     Translational immunology (cell therapies, antibody engineering, and xenotransplantation)
●     Industrial bioprocesses for drug production and development
●     Biosafety
●     Biotech ethics

Special Issues devoted to crucial topics, providing the latest comprehensive information on cutting-edge areas of research and technological advances, are welcome.

Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government, and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.

Current Pharmaceutical Biotechnology is an international, peer-reviewed journal on all the developments in pharmaceutical biotechnology, published biweekly (print & online) by Bentham Science Publishers.

Morty Proxy This is a proxified and sanitized view of the page, visit original site.